Detalles de la búsqueda
1.
Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.
Asian Pac J Allergy Immunol
; 40(3): 223-231, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32247304
Resultados
1 -
1
de 1
1
Próxima >
>>